Oral and parenteral hypoglycaemics

Guidelines (10)
Tables (1)

Table: Antidiabetic Agents, Use in Renal Impairment

Dosing of diabetes drugs in patients with renal impairment.

Oral and parenteral hypoglycaemics in the News

Reduce insulin doses carefully when starting GLP-1 agonists, MHRA advises

Reduce insulin doses carefully when starting GLP-1 agonists, MHRA advises

A careful stepwise approach is needed when reducing...

NICE recommends new triple therapy option for diabetes

NICE recommends new triple therapy option for diabetes

Ertugliflozin (Steglatro) can now be prescribed routinely...

Second DPP4 inhibitor/SGLT2 inhibitor tablet launched for patients with diabetes

Second DPP4 inhibitor/SGLT2 inhibitor tablet launched for patients with diabetes

Prescribers can now consider Glyxambi (linagliptin/empagliflozin)...